Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Downing

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
BMC Psychiatry|December 26, 2014
A Double-Blind, Placebo-Controlled Comparator Study of LY2140023 monohydrate in patients with schizophreniaAnnCatherine M Downing, Bruce J Kinon, Brian A Millen, et al.
Science Advances|December 15, 2021
Chromatin architecture at susceptible gene loci in cerebellar Purkinje cells characterizes DNA damage-induced neurodegenerationYoung Don Kwak, Timothy I Shaw, Susanna M Downing, et al.
Nature Neuroscience|May 6, 2014
Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative genome instability syndromesSachin Katyal, Youngsoo Lee, Karin C Nitiss, et al.
American Journal of Epidemiology|April 8, 2017
Food Environment and Weight Change: Does Residential Mobility Matter?: The Diabetes Study of Northern California (DISTANCE)Barbara A Laraia, Janelle M Downing, Y Tara Zhang, et al.
Journal of Medicinal Chemistry|October 14, 1994
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agentsJ L Wright, B W Caprathe, D M Downing, et al.
Journal of Inherited Metabolic Disease|May 11, 1999
The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial diseaseJ R Bonham, P Guthrie, M Downing, et al.
BMC Geriatrics|October 18, 2018
Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer's disease in an administrative claims databaseRadhika Nair, Virginia S Haynes, Mir Siadaty, et al.
Energy & Environmental Science|September 1, 2020
Morphology Changes Upon Scaling a High-Efficiency, Solution-Processed Solar Cell From Spin-Coating to Roll-to-Roll CoatingHyun Wook Ro, Jonathan M Downing, Sebastian Engmann, et al.
Journal of Inherited Metabolic Disease|April 5, 2001
Features of carnitine palmitoyltransferase type I deficiencyS E Olpin, J Allen, J R Bonham, et al.
Neuropathology and Applied Neurobiology|June 9, 2023
Simultaneous Nbs1 and p53 inactivation in neural progenitors triggers high-grade gliomasDavid E Reuss, Susanna M Downing, Cristel V Camacho, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
BMC Psychiatry|December 26, 2014
A Double-Blind, Placebo-Controlled Comparator Study of LY2140023 monohydrate in patients with schizophreniaAnnCatherine M Downing, Bruce J Kinon, Brian A Millen, et al.
Science Advances|December 15, 2021
Chromatin architecture at susceptible gene loci in cerebellar Purkinje cells characterizes DNA damage-induced neurodegenerationYoung Don Kwak, Timothy I Shaw, Susanna M Downing, et al.
Nature Neuroscience|May 6, 2014
Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative genome instability syndromesSachin Katyal, Youngsoo Lee, Karin C Nitiss, et al.
American Journal of Epidemiology|April 8, 2017
Food Environment and Weight Change: Does Residential Mobility Matter?: The Diabetes Study of Northern California (DISTANCE)Barbara A Laraia, Janelle M Downing, Y Tara Zhang, et al.
Journal of Medicinal Chemistry|October 14, 1994
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agentsJ L Wright, B W Caprathe, D M Downing, et al.
Journal of Inherited Metabolic Disease|May 11, 1999
The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial diseaseJ R Bonham, P Guthrie, M Downing, et al.
BMC Geriatrics|October 18, 2018
Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer's disease in an administrative claims databaseRadhika Nair, Virginia S Haynes, Mir Siadaty, et al.
Energy & Environmental Science|September 1, 2020
Morphology Changes Upon Scaling a High-Efficiency, Solution-Processed Solar Cell From Spin-Coating to Roll-to-Roll CoatingHyun Wook Ro, Jonathan M Downing, Sebastian Engmann, et al.
Journal of Inherited Metabolic Disease|April 5, 2001
Features of carnitine palmitoyltransferase type I deficiencyS E Olpin, J Allen, J R Bonham, et al.
Neuropathology and Applied Neurobiology|June 9, 2023
Simultaneous Nbs1 and p53 inactivation in neural progenitors triggers high-grade gliomasDavid E Reuss, Susanna M Downing, Cristel V Camacho, et al.
Pageof 17